Across TCGA pan-cancer cohorts, OR5P2 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated OR5P2 data layer compared with 13 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher OR5P2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated OR5P2 expression acts as an unfavorable survival marker.

HNSC, SARC, and SKCM are the cancer types where OR5P2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.162	0.685	.018	24	view →
SARC	OS	Median	All	0.567	0.859	.038	5	view →
SKCM	OS	Median	IV	0.415	0.861	.014	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: OR5P2 tumor-vs-normal RNA expression · all OR5P2 data types